Manulife (Manufacturers Life Insurance)
FOLD

Manulife (Manufacturers Life Insurance)’s Amicus Therapeutics FOLD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
89,337
-56,104
-39% -$804K ﹤0.01% 1698
2025
Q4 		$2.07M Sell
145,441
-2,808
-2% -$27.6K ﹤0.01% 1506
2025
Q3 		$1.17M Sell
148,249
-3,611
-2% -$25.7K ﹤0.01% 1777
2025
Q2 		$870K Sell
151,860
-10,763
-7% -$69.5K ﹤0.01% 1891
2025
Q1 		$1.33M Buy
162,623
+5,835
+4% +$54K ﹤0.01% 1669
2024
Q4 		$1.48M Sell
156,788
-4,214
-3% -$43.8K ﹤0.01% 1706
2024
Q3 		$1.72M Sell
161,002
-11,301
-7% -$123K ﹤0.01% 1626
2024
Q2 		$1.71M Buy
172,303
+8,509
+5% +$87.3K ﹤0.01% 1555
2024
Q1 		$1.93M Buy
163,794
+13,798
+9% +$176K ﹤0.01% 1530
2023
Q4 		$2.13M Sell
149,996
-53
-0% -$602 ﹤0.01% 1453
2023
Q3 		$1.82M Buy
150,049
+36,669
+32% +$473K ﹤0.01% 1469
2023
Q2 		$1.42M Buy
113,380
+2,008
+2% +$23.8K ﹤0.01% 1508
2023
Q1 		$1.24M Buy
111,372
+1,323
+1% +$16.3K ﹤0.01% 1533
2022
Q4 		$1.34M Buy
110,049
+746
+0.7% +$8.4K ﹤0.01% 1501
2022
Q3 		$1.14M Sell
109,303
-1,948
-2% -$21.7K ﹤0.01% 1550
2022
Q2 		$1.19M Buy
111,251
+2,176
+2% +$17.9K ﹤0.01% 1573
2022
Q1 		$1.03M Sell
109,075
-25,248
-19% -$237K ﹤0.01% 1735
2021
Q4 		$1.55K Sell
134,323
-1,710
-1% -$19.1K ﹤0.01% 1602
2021
Q3 		$1.3M Sell
136,033
-12,559
-8% -$128K ﹤0.01% 1674
2021
Q2 		$1.43M Buy
148,592
+3,317
+2% +$32.4K ﹤0.01% 1776
2021
Q1 		$1.44M Sell
145,275
-8,017
-5% -$124K ﹤0.01% 1691
2020
Q4 		$3.54M Buy
153,292
+6,319
+4% +$129K ﹤0.01% 1352
2020
Q3 		$2.08M Sell
146,973
-4,201
-3% -$61.2K ﹤0.01% 1415
2020
Q2 		$2.35M Sell
151,174
-11,093
-7% -$135K ﹤0.01% 1364
2020
Q1 		$1.5M Buy
162,267
+8,759
+6% +$83.3K ﹤0.01% 1395
2019
Q4 		$1.5M Sell
153,508
-1,739
-1% -$15.9K ﹤0.01% 1505
2019
Q3 		$1.25M Buy
155,247
+2,256
+1% +$24.5K ﹤0.01% 1545
2019
Q2 		$1.91M Buy
152,991
+30,071
+24% +$382K ﹤0.01% 1394
2019
Q1 		$1.67M Sell
122,920
-6,536
-5% -$79.8K ﹤0.01% 1474
2018
Q4 		$1.24M Buy
129,456
+7,041
+6% +$77.4K ﹤0.01% 1509
2018
Q3 		$1.48M Sell
122,415
-16,523
-12% -$231K ﹤0.01% 1570
2018
Q2 		$2.17M Sell
138,938
-679
-0.5% -$10.3K ﹤0.01% 1470
2018
Q1 		$2.1M Buy
139,617
+12,592
+10% +$192K ﹤0.01% 1474
2017
Q4 		$1.83M Buy
127,025
+1,677
+1% +$23K ﹤0.01% 1523
2017
Q3 		$1.89M Buy
125,348
+13,780
+12% +$182K ﹤0.01% 1457
2017
Q2 		$1.12M Sell
111,568
-44
-0% -$354 ﹤0.01% 1738
2017
Q1 		$796K Buy
111,612
+13,456
+14% +$85.1K ﹤0.01% 1865
2016
Q4 		$487K Buy
98,156
+10,118
+11% +$70K ﹤0.01% 2112
2016
Q3 		$652K Sell
88,038
-313
-0.4% -$2.11K ﹤0.01% 1908
2016
Q2 		$482K Sell
88,351
-156,225
-64% -$1.09M ﹤0.01% 2061
2016
Q1 		$1.95M Buy
244,576
+1,784
+0.7% +$12.6K ﹤0.01% 1400
2015
Q4 		$2.35K Buy
242,792
+857
+0.4% +$7.72K ﹤0.01% 1361
2015
Q3 		$3.38K Sell
241,935
-18,360
-7% -$288K ﹤0.01% 1203
2015
Q2 		$3.68K Buy
260,295
+257,874
+10,652% +$3.1M ﹤0.01% 1205
2015
Q1 		$26 Hold
2,421
– – ﹤0.01% 3435
2014
Q4 		$20 Buy
2,421
+2,070
+590% +$14.2K ﹤0.01% 3376
2014
Q3 		$2 Hold
351
– – ﹤0.01% 3767
2014
Q2 		$1K Hold
351
– – ﹤0.01% 3775
2014
Q1 		$1 Hold
351
– – ﹤0.01% 3717
2013
Q4 		$1 Sell
351
-2,133
-86% -$4.68K ﹤0.01% 3733
2013
Q3 		$6 Hold
2,484
– – ﹤0.01% 3323
2013
Q2 		$6K Buy
+2,484
New +$7.63K ﹤0.01% 3236

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FOLD Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Amicus Therapeutics (FOLD) stake by 39% in Q1 2026, selling an estimated $804K and leaving 89,337 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Manulife (Manufacturers Life Insurance) first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.54M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 89,337 shares of Amicus Therapeutics worth $1.29M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 56,104 Amicus Therapeutics shares in Q1 2026, an estimated $804K.
  • Amicus Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1698 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Amicus Therapeutics position peaked at $3.54M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.